Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | SANA | SANA BIOTECHNOLOGY INC | Healthcare | 43,404.0 | $177K | 0.01% | -2K | -4.3% | $4.07 | -24.6% |
| 142 | — | GLOBUS MEDICAL INC - A | — | 2,000.0 | $175K | 0.01% | -3K | -60.0% | $87.31 | — |
| 143 | ERAS | ERASCA INC | Healthcare | 46,231.0 | $172K | 0.01% | -3K | -7.0% | $3.72 | +202.2% |
| 144 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 18,874.0 | $170K | 0.01% | -20K | -51.4% | $8.99 | +40.2% |
| 145 | LI | LI AUTO INC - ADR | Consumer Cyclical | 10,000.0 | $169K | 0.01% | -20K | -66.7% | $16.93 | -6.1% |
| 146 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 48,777.0 | $167K | 0.01% | -4K | -6.9% | $3.42 | +52.0% |
| 147 | DEO | DIAGEO PLC-SPONSORED ADR | Consumer Defensive | 1,884.0 | $163K | 0.01% | -2K | -54.2% | $86.27 | -0.2% |
| 148 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 5,000.0 | $157K | 0.01% | -3K | -37.5% | $31.46 | -7.8% |
| 149 | DAWN | DAY ONE BIOPHARMACEUTICALS I | Healthcare | 16,731.0 | $156K | 0.01% | -1K | -6.8% | $9.32 | +131.0% |
| 150 | ALMS | ALUMIS INC | Healthcare | 15,840.0 | $155K | 0.01% | -1K | -6.7% | $9.76 | +125.6% |
| 151 | TBPH | THERAVANCE BIOPHARMA INC | Healthcare | 8,257.0 | $154K | 0.01% | -571.0 | -6.5% | $18.71 | -12.5% |
| 152 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 31,339.0 | $151K | 0.01% | -2K | -6.7% | $4.81 | -9.6% |
| 153 | CRMD | CORMEDIX INC | Healthcare | 12,839.0 | $149K | 0.01% | -246.0 | -1.9% | $11.63 | -31.4% |
| 154 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 9,671.0 | $149K | 0.01% | -712.0 | -6.9% | $15.40 | +169.7% |
| 155 | KURA | KURA ONCOLOGY INC | Healthcare | 14,179.0 | $147K | 0.01% | -1K | -6.8% | $10.39 | +8.3% |
| 156 | — | MESOBLAST LTD- SPON ADR | — | 7,992.0 | $144K | 0.01% | -284.0 | -3.4% | $18.04 | — |
| 157 | GERN | GERON CORP | Healthcare | 104,020.0 | $137K | 0.01% | -8K | -7.0% | $1.32 | -3.0% |
| 158 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 22,670.0 | $137K | 0.01% | -2K | -6.9% | $6.03 | +52.4% |
| 159 | ON | ON SEMICONDUCTOR | Technology | 2,500.0 | $135K | 0.01% | -11K | -81.2% | $54.15 | +114.6% |
| 160 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 6,727.0 | $135K | 0.01% | -384.0 | -5.4% | $20.12 | +32.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%